Rock River Capital Partners — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Atrilityatrility.comNov 2025
Atrility develops cardiac medical devices, including the AtriAmp for post-operative arrhythmia monitoring, aimed at improving care for cardiac patients.
HardwareHealthtechMedical DevicesMadison, US
Matt Knoespel(VP of Commercialization, Founder)Phil Terrien(VP of Operations, Founder)inNick Von Bergen, M.D.(CMO, Board Member, Founder)Pete Lukszys(Senior Advisor, Founder)Sean McCormick(CEO, Board Member)inMike Bress(CFO)
Board seatChristopher Eckstrom· per SEC Form D
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

